Parexel unveils new integrated FPS model to boost clinical research
Category: #health  By Mateen Dalal  Date: 2019-06-24
  • share
  • Twitter
  • Facebook
  • LinkedIn

Parexel unveils new integrated FPS model to boost clinical research

Parexel stands as a pioneer in the delivery and development of a wide range of FSP, with full and flexible clinical development services

Parexel, a leading global provider of biopharmaceutical services and innovative therapies, recently announced that it has launched an enhanced integrated delivery model aimed at Functional Service Provider (FSP) services, in San Diego at the DIA 2019 Global Annual Meeting.

Reportedly, Parexel FSP reflects the strategic focus the company has towards offering solutions that are patient-focused and are tailored according to biopharma customers’ changing needs, ranging from full service to a functional and a hybrid approach.

Resources and multifunctional expertise are accessible to the customers through a single point of contact, while simultaneously maintaining business productivity and continuity to reduce complexity, drive efficiency and accelerate time to market, sources familiar with the matter informed.

Parexel’s Executive Vice President and Chief Commercial & Strategy Officer, Peyton Howell said that biopharma companies need hybrid and flexible approaches to their needs of outsourcing, owing to related blended models with functional services that represent a major proportion of the total clinical development.

Parexel supposedly has a proven track record in delivering and connecting targeted needs with an enhanced expertise in functional services and capability to integrate with the teams of their customers.

Apparently, Parexel stands as a pioneer in the delivery and development of a wide range of FSP, with full and flexible clinical development services and has delivered over 1,400 projects.

Parexel is able to leverage the company’s TMAC and ExecuPharm subsidiaries and the company’s broader FSP offers to provide hybrid capability and comprehensive FSP which stands unparalleled in the industry, Howell noted. For instance, ExecuPharm subsidiary provides qualified professionals to customers across functional areas that include study management and clinical monitoring.

For the record, biopharma customers have recognized Parexel and its ExecuPharm subsidiary for their FSP services. Moreover, ExecuPharm subsidiary has won multiple accolades for innovation and excellence over the past several years with Parexel being recognized for its FSP with an innovation award.

 

Source Credit- https://www.parexel.com/news-events-resources/news/current/parexel-launches-enhanced-integrated-functional-service-provider-model-drive-delivery-innovative-clinical-research-partnerships

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ather Energy raises $250 million to stay ahead in competition
Ather Energy raises $250 million to stay ahead in competition
By Mateen Dalal

Electric scooter producer Ather Energy has reportedly secured $250 million in a new funding round. As per reports, the investment round is in its early stages. The company’s goal is to obtain $200 million to $250 million to compete in the EV...

Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
By Mateen Dalal

Mojocare, a wellness and health startup has reportedly raised USD 20.6 million in a Series A round of funding which was led by B Capital Group and saw participation from existing investors including Sequoia India’s Surge, Better Capital, and Ch...

Exponent Energy bags USD 13 million in Lightspeed-led Series A funding
Exponent Energy bags USD 13 million in Lightspeed-led Series A funding
By Mateen Dalal

Bangalore-based Exponent Energy has reportedly secured USD 13 million in a Series A funding round which was spearheaded by Lightspeed Venture Partners. The round also saw participation from existing investors such as 3one4 Capital, YourNest VC, and A...